Cargando…
BSLD-01 DYNAMIC CONTROL OF CSF FOR PERSONALIZED CNS DRUG DELIVERY FOR LEPTOMINGEAL DISEASE
BACKGROUND: Appropriate drug distribution is needed for effective treatment of brain metastases and leptomeningeal disease. Lack of proper drug bioavailability in the CNS contributes to the poor outcome in these patients. EnClear Therapies has developed a device delivering intrathecal therapeutics u...
Autores principales: | Kumthekar, Priya, Benatti, Hector Ribeiro, Taghian, Toloo, Nagpal, Seema, Gormley, William, Baker, William, Patel, Rajan, Brown, Emma, Glicksman, Marcie, Gray-Edwards, Heather |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402341/ http://dx.doi.org/10.1093/noajnl/vdad070.019 |
Ejemplares similares
-
BSLD-03 MIMICKING CAFS, PIAL CELLS SUPPORTLEPTOMENINGEAL METASTASIS
por: Snyder, Jenna, et al.
Publicado: (2023) -
BSLD-05 ESTABLISHMENT AND CHARACTERIZATION OF MOUSE MODELS OF LEPTOMENINGEAL METASTASIS
por: Derderian, Camille, et al.
Publicado: (2023) -
BSLD-06 UNVEILING THE RE-PROGRAMMING OF CHOROID PLEXUS AND LEPTOMENINGEAL METASTASIS
por: Nobre, Ana Rita, et al.
Publicado: (2023) -
BSLD-02 ELUCIDATING LEPTOMENINGEAL MICROENVIRONMENT CUES THAT PROMOTE METASTASIS AND CHEMOTHERAPY RESISTANCE IN HIGH-RISK MEDULLOBLASTOMA
por: Reinecke, James, et al.
Publicado: (2023) -
NEIM-15 AN EXCEPTION TO THE METASTATIC RULE: A NON-ENHANCING MIDBRAIN LESION DUE TO METASTATIC FIBROMYXOID SARCOMA WITH EXTENSIVEINFLAMMATORY INFILTRATE
por: Rogawski, David, et al.
Publicado: (2023)